We have 2 new companies:
- AKEBIA THERAPEUTICS, INC. (CAMBRIDGE, MA), PHARMACEUTICAL PREPARATIONS
- Q2 HOLDINGS, INC. (AUSTIN, TX), PREPACKAGED SOFTWARE
We have 40 new people:
- ADOX JAMES R, a major shareholder at AKEBIA THERAPEUTICS, INC.
- ANDERSON ADAM D, EVP, CHIEF TECHNOLOGY OFFICER at Q2 HOLDINGS, INC.
- ARIDA GEORGE, a major shareholder at AKEBIA THERAPEUTICS, INC.
- BEDFORD JOHN S II, VP, CORPORATE CONTROLLER at ETHAN ALLEN INTERIORS INC
- BENTON BARRY G, SVP, GENERAL COUNSEL at Q2 HOLDINGS, INC.
- BREEDEN JOHN E, EVP, OPERATIONS at Q2 HOLDINGS, INC.
- BUTTON SCOTT, a major shareholder at AKEBIA THERAPEUTICS, INC.
- CLANEY KELVIN, CHIEF EXECUTIVE OFFICER at INTERNATIONAL COMMERCIAL TELEVISION INC
- DALAL ANUPAM, a Director at AKEBIA THERAPEUTICS, INC.
- DIEHL BOWEN S, SVP AND CIO at CAPITAL SOUTHWEST CORP
- DUDA NATHAN, a person at BANC OF CALIFORNIA, INC.
- DUEHOLM KIM, a Director at AKEBIA THERAPEUTICS, INC.
- ELKINS CYNTHIA, a Director at WEIGHT WATCHERS INTERNATIONAL INC
- FALA HERMAN C, GENERAL COUNSEL at LIBERTY PROPERTY TRUST
- FENDLEY SANDRA, VP, CHIEF ACCOUNTING OFFICER at MATADOR RESOURCES CO
- FLAKE MATTHEW P, PRESIDENT AND CEO at Q2 HOLDINGS, INC.
- FURRER WILLIAM M, SVP, PRODUCT AND MARKETING at Q2 HOLDINGS, INC.
- GANSER ROGER H, a major shareholder at AKEBIA THERAPEUTICS, INC.
- HADAS NICOLE R., SEE REMARKS at AKEBIA THERAPEUTICS, INC.
- HARRIS JENNIFER NOEL, CHIEF FINANCIAL OFFICER at Q2 HOLDINGS, INC.
- HESTON SARA C, VP INVESTMENTS at ASA GOLD & PRECIOUS METALS LTD
- HOFFMAN MICHELLE, VP SALES at BUCKLE INC
- HUANG KELLY, SVP-CONSUMER SECTOR at INTREXON CORP
- KEATING THOMAS, CHIEF FINANCIAL OFFICER at BCB BANCORP INC
- KRAMER STEPHEN HOWARD, CHIEF DEVELOPMENT OFFICER at BRIGHT HORIZONS FAMILY SOLUTIONS INC.
- MAYO SCOTT A, SVP, BGI; PRES., INDUSTRIAL at BARNES GROUP INC
- NASH DUANE, a Director at AKEBIA THERAPEUTICS, INC.
- NIELSEN JACK, a Director at AKEBIA THERAPEUTICS, INC.
- NIMRODI NIR, SVP-ENVIRONMENT SECTOR at INTREXON CORP
- PETERSON LOREN G, a major shareholder at AKEBIA THERAPEUTICS, INC.
- PETRY PAUL E, a Director at BSB BANCORP, INC.
- QUINN PATRICK J, a Director at NATIONAL PRESTO INDUSTRIES INC
- SANDOVAL VINCENT, VP AND GRPPRES AERO-DEFENSE at CIRCOR INTERNATIONAL INC
- SANDS MICHAEL A, EVP OF SNACKS at B&G FOODS, INC.
- SEALE R. H., CHAIRMAN at Q2 HOLDINGS, INC.
- SHALABY RICK, SVP SALES at PERNIX THERAPEUTICS HOLDINGS, INC.
- SHALWITZ ROBERT, CHIEF MEDICAL OFFICER at AKEBIA THERAPEUTICS, INC.
- SINGER RICHARD JOHN, MANAGING DIRECTOR, EUROPE at TRAVELZOO INC
- SOUKUP STEPHEN C, SVP, SALES at Q2 HOLDINGS, INC.
- WISEMAN ROBERT B, CTO at ANGIE'S LIST, INC.
We have 30 new positions:
- AMELLO JASON, becomes SVP, CFO & TREASURER at AKEBIA THERAPEUTICS, INC.
- BROWN MICHAEL MAURICE, becomes a Director at Q2 HOLDINGS, INC.
- BUTLER JOHN P., becomes SEE REMARKS at AKEBIA THERAPEUTICS, INC.
- DECKER PATRICK, becomes PRESIDENT & CEO at XYLEM INC.
- DIEHL JEFFREY T, becomes a Director at Q2 HOLDINGS, INC.
- DOURNEY ROBERT J, becomes CEO AND PRESIDENT at COSI INC
- DOYLE CHARLES T, becomes a Director at Q2 HOLDINGS, INC.
- ENGLANDER DANIEL J, becomes a Director at HEALTHWAYS, INC
- GOLDBERG MARK ALAN, becomes a Director at IDERA PHARMACEUTICALS, INC.
- HALL SUSAN, becomes EVP, CSO, GLOBAL HEAD OF R&D at ENDO INTERNATIONAL PLC
- HALVORSON DAN L, becomes a Director at SUPERCONDUCTOR TECHNOLOGIES INC
- HANSEN BRUCE D, becomes a Director at ASA GOLD & PRECIOUS METALS LTD
- HOENE MARY JOAN, becomes a Director at ASA GOLD & PRECIOUS METALS LTD
- HOOPER JOHN A, becomes a person at STANCORP FINANCIAL GROUP INC
- HOUGHTON KEITH J, becomes SVP, CHIEF CREDIT OFFICER at HOMETRUST BANCSHARES, INC.
- JOTWANI PRADEEP, becomes a Director at ACCO BRANDS CORP
- LUTHER MICHAEL A, becomes a Director at TRANSGENOMIC INC
- MAPLES MICHAEL J, becomes a Director at Q2 HOLDINGS, INC.
- MOORE LINDA V, becomes GENERAL COUNSEL at MARRONE BIO INNOVATIONS INC
- NEIS JOHN, becomes a major shareholder at AKEBIA THERAPEUTICS, INC.
- OFFERDAHL JAMES, becomes a Director at Q2 HOLDINGS, INC.
- RADOFF BRADLEY LOUIS, becomes a major shareholder at OPTIMIZERX CORP
- ROBERTS JAMES E, becomes SVP, REINSURANCE at TOWER GROUP INTERNATIONAL, LTD.
- ROSENFELD STEVEN R, becomes a major shareholder at STALAR 1, INC.
- SATTER MUNEER A, becomes a Director at AKEBIA THERAPEUTICS, INC.
- SCHAPER CARL JAMES, becomes a Director at Q2 HOLDINGS, INC.
- SEIFERT THOMAS J, becomes EVP & CHIEF FINANCIAL OFFICER at SYMANTEC CORP
- WALBERT TIMOTHY P, becomes a Director at EGALET CORP
- WEISS PAUL M, becomes a major shareholder at AKEBIA THERAPEUTICS, INC.
- WYZGA MICHAEL S, becomes a Director at AKEBIA THERAPEUTICS, INC.
No comments:
Post a Comment